Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Coronavirus main protease is essential for viral polyprotein processing and replication. Here Vuong et al. report efficient inhibition of SARS-CoV-2 replication by the dipeptide-based protease inhibitor GC376 and its parent GC373, which were originally used to treat feline coronavirus infection.
Main Authors: | Wayne Vuong, Muhammad Bashir Khan, Conrad Fischer, Elena Arutyunova, Tess Lamer, Justin Shields, Holly A. Saffran, Ryan T. McKay, Marco J. van Belkum, Michael A. Joyce, Howard S. Young, D. Lorne Tyrrell, John C. Vederas, M. Joanne Lemieux |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2020-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-18096-2 |
Similar Items
-
Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
by: Wayne Vuong, et al.
Published: (2020-10-01) -
Crystallization of Feline Coronavirus Mpro With GC376 Reveals Mechanism of Inhibition
by: Jimmy Lu, et al.
Published: (2022-02-01) -
The Effect of Deuteration and Homologation of the Lactam Ring of Nirmatrelvir on Its Biochemical Properties and Oxidative Metabolism
by: Elena Arutyunova, et al.
Published: (2023-11-01) -
Simplified cloning and isolation of peptides from “sandwiched” SUMO-peptide-intein fusion proteins
by: Tess Lamer, et al.
Published: (2023-04-01) -
Lactococcus lactis mutants resistant to lactococcin A and garvicin Q reveal missense mutations in the sugar transport domain of the mannose phosphotransferase system
by: Marco J. van Belkum, et al.
Published: (2024-01-01)